Van der Galien HT, Kooistra HA, Veeger NJGM, et al. Outcome of a 10-year population-based cohort of diffuse large B-cell lymphoma patients in the first-line, refractory and relapsed setting: ‘real world’ data identify subgroups in need of new therapies. EHA 2018; poster PF287.
Betere overleving pPCL met VRd of daratumumab-gebaseerde quadrupeltherapie
apr 2023 | Leukemie, MM